MarketPeel
Insider Trading Intelligence
BP

Brian Jg Pereira

KALV
DIRECTOR · KALVISTA PHARMACEUTICALS, INC. · CIK 0001298146
FILING MIX · LIFETIME56%/44%
BUYS
15
SELLS
12
TOTAL VALUE
$1.88M
COMPANIES
3
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
1,065,000
AVG SELL PX
$2.49
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brian Jg Pereira, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%-10.88%-2.97%-7.91%-7.91%
14d4+100.00%-13.96%+0.30%-14.25%-14.25%
30d4+100.00%-10.30%+0.60%-10.91%-10.91%
60d4+50.00%-5.43%+2.58%-8.02%-8.02%
90d4+100.00%-18.64%+2.12%-20.76%-20.76%
180d4+100.00%-27.94%+9.01%-36.95%-36.95%
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KALV · 0 shares · as of Jun 11, 2026
07,50015,00022,50030,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 12 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KALV
KALVISTA PHARMACEUTICALS, INC.
SALE
7,0000Jun 11, 2026Jun 11, 2026View →
KALV
KALVISTA PHARMACEUTICALS, INC.
SALE
10,0000Jun 11, 2026Jun 11, 2026View →
KALV
KALVISTA PHARMACEUTICALS, INC.
SALE
14,0000Jun 11, 2026Jun 11, 2026View →
KALV
KALVISTA PHARMACEUTICALS, INC.
SALE
30,0000Jun 11, 2026Jun 11, 2026View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
135,000135,000May 28, 2026May 29, 2026View →
PROK
PROKIDNEY CORP.
SALE
447,803$2.37$1.06M0Nov 13, 2025Nov 14, 2025View →
PROK
PROKIDNEY CORP.
SALE
54,333$2.37$128.8K0Nov 13, 2025Nov 14, 2025View →
PROK
PROKIDNEY CORP.
SALE
227,431$2.72$619.4K447,803Nov 12, 2025Nov 14, 2025View →
PROK
PROKIDNEY CORP.
SALE
27,595$2.72$75.2K54,333Nov 12, 2025Nov 14, 2025View →
KALV
KALVISTA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Oct 1, 2025Oct 2, 2025View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
125,862125,862May 29, 2025Jun 2, 2025View →
PROK
PROKIDNEY CORP.
SALE
81,92881,929Feb 4, 2025Feb 6, 2025View →
PROK
PROKIDNEY CORP.
PURCHASE
675,234675,234Feb 4, 2025Feb 6, 2025View →
PROK
PROKIDNEY CORP.
SALE
81,92881,929Feb 4, 2025Feb 6, 2025View →
PROK
PROKIDNEY CORP.
SALE
675,234675,235Feb 4, 2025Feb 6, 2025View →
PROK
PROKIDNEY CORP.
SALE
675,234675,235Feb 4, 2025Feb 6, 2025View →
PROK
PROKIDNEY CORP.
PURCHASE
81,92881,928Feb 4, 2025Feb 6, 2025View →
KALV
KALVISTA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Oct 3, 2024Oct 4, 2024View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
62,55862,558May 30, 2024Jun 3, 2024View →
KALV
KALVISTA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Sep 26, 2023Sep 28, 2023View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
48,12848,128Jun 29, 2023Jul 3, 2023View →
KALV
KALVISTA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Oct 13, 2022Oct 17, 2022View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
1,514,3261,514,326Jul 11, 2022Jul 13, 2022View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
1,514,3261,514,326Jul 11, 2022Jul 13, 2022View →
KALV
KALVISTA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Sep 30, 2021Oct 1, 2021View →
KALV
KALVISTA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,0007,000Oct 1, 2020Oct 2, 2020View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
930,000930,000Apr 15, 2020Apr 17, 2020View →
Other insiders · KALV
Loading peer insiders…
About this filer
CIK 0001298146
ROLE
Director
PRIMARY
KALV
COMPANIES
3
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001298146DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback